4//SEC Filing
McDowell Glenn 4
Accession 0001209191-18-019523
CIK 0000885978other
Filed
Mar 13, 8:00 PM ET
Accepted
Mar 14, 3:56 PM ET
Size
7.7 KB
Accession
0001209191-18-019523
Insider Transaction Report
Form 4
McDowell Glenn
Chief Operating Officer
Transactions
- Sale
Common Stock
2018-03-12$86.16/sh−2,538$218,674→ 31,219 total - Sale
Common Stock
2018-03-13$85.45/sh−205$17,517→ 31,014 total
Footnotes (3)
- [F1]The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $86.15 - $86.25, both inclusive. The reporting person undertakes to provide to U.S. Physical Therapy, Inc., any of its shareholders or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.
- [F2]Includes 26,935 shares of restricted stock granted under the Company's equity plans. Restrictions lapse as to 3,102 shares on each of April 1, 2018, July 1, 2018, October 1, 2018 and January 1, 2019; 1,852 shares on each of April 1, 2019, July 1, 2019, October 1, 2019 and January 1, 2020; and 1,142 shares on each of April 1, July 1 and October 1, 2020; 1,157 shares on January 1, 2021; 632 shares on each of April 1, July 1 and October 1, 2021; and 640 shares on January 1, 2022.
- [F3]The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $85.45 - $85.55, both inclusive. The reporting person undertakes to provide to U.S. Physical Therapy, Inc., any of its shareholders or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.
Documents
Issuer
U S PHYSICAL THERAPY INC /NV
CIK 0000885978
Entity typeother
Related Parties
1- filerCIK 0001315304
Filing Metadata
- Form type
- 4
- Filed
- Mar 13, 8:00 PM ET
- Accepted
- Mar 14, 3:56 PM ET
- Size
- 7.7 KB